Stakeholders of all stripes have wondered whether transcatheter aortic valve replacement devices could match their surgically implanted cousins for device durability, but seven-year data from the Partner 3 trial seems to suggest that patients, physicians, payers and regulators need not fret as the topline numbers showed no statistically significant difference for outcomes such as mortality and morbidity. Read More
Medtronic plc’s SPYRAL HTN-ON MED trial demonstrated significantly greater reduction in blood pressure with the Symplicity Spyral renal denervation procedure at three years than a sham procedure in a study presented as featured clinical research at the 2025 Transcatheter Cardiovascular Therapeutics conference in San Francisco. Read More
Cordis Corp. has quite a bit to crow about in this latter part of October 2025 with the unveiling of results of two studies that back the Miami Lakes, Fla.-based company’s Selution SLR drug-eluting balloon (DEB) for both de novo coronary artery stenosis and in-stent restenosis. Read More
Private equity firm GHO Capital raised more than €2.5 billion (US$2.9 billion) for its latest fund to invest in health care companies. The fund, GHO Capital IV LP, is the firm’s largest to date and comes despite a challenging market environment reflecting confidence from investors in GHO’s transatlantic strategy and proven record of outperformance across the health care ecosystem. Read More
What trends in life sciences have defined the last three decades? BioWorld Editor Nuala Moran picks monoclonal antibodies as the most significant. “They are the cornerstone around which medical biotechnology as a sector has been built.” Read More
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cardiosense, Medtronic, Mercy Bioanalytics, Natera, Pleural Dynamics, Smith+Nephew. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Altius, Atricure, Augurex, Cardiovascular Research Foundation, Carl Zeiss, Fibronostics, Fogarty Innovation, Heartbeam, Intelerad, Laborie, Lifescan, Orchestra Biomed, QT Imaging, Stone Clincal Laboratories, Syd Life AI, Terumo, University of Galway, Zimmer Biomet. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bot Image. Read More
